SciVentures Investments

The Riverside Company is a global private equity firm focused exclusively on mid-market growth businesses valued at up to $400 million. Since its founding in 1988, Riverside has invested in more than 520 transactions. We bring strong operational and financial resources and pride ourselves on being a good partner. We prefer to partner with sellers seeking to remain involved in the company as we work together to enhance processes, expand product offerings and attract new customers. We move quickly for compelling opportunities, and can close transactions within 30 to 90 days.

BGH Capital is an Australian private equity firm founded in 2017. It focuses on buyout and growth investments across a range of industries in Australia and New Zealand.

Wingate is an Australian private credit investment manager focused on real estate and mid-market corporate debt. Its corporate strategy provides working capital and senior financing to businesses. CapitaLand Investment acquired Wingate’s property and corporate credit investment management business in 2025.

Portland House Group is the Melbourne investment vehicle of the Hains family. Established by David Hains, the group has invested family capital across global equities, fixed income, property and external funds.

LJCB Investment Group is an investment office of the Melbourne-based Liberman family. Joshua Liberman chaired the group, whose interests have included real estate.

RF Corval is a dedicated property investor and fund manager. We manage funds on behalf of broad range of investors, including large Australian institutions, family offices, offshore groups and both high net worth and retail investors. We currently manage a portfolio of more than 20 investments with a team of 11 real estate professionals who are dedicated to exceeding its investors' objectives. RF Corval is a private company that is owned by the senior management team and RF Capital, a vehicle associated with Andrew Roberts, the CEO of the previously ASX-listed Multiplex Group, prior to the takeover of that company by Brookfield Asset Management

Thorney Investment Group is the private investment group Alex Waislitz founded in 1991. It invests in listed and unlisted businesses and takes an active role with boards and management. The group also has listed investment companies and a property business.

Advent Partners is a Melbourne based private equity firm specialising in mid-market businesses. It is one of Australia's most experienced managers, having invested in more than 90 companies over more than 30 years. Advent has a clear investment criteria: it focuses on privately owned businesses in growing markets, with strong management tearms, operating profits if $5 to $30 million, and enterprise values of $20 to $150 million. Advent can do both minority and majority investments, with shareholdings ranging from 33 to 95%. It usually seeks to exit within three to five years. Advent has a broad industry focus, with the only exceptions being property development, agriculture and resources.

Tanarra is a diversified investment manager investing for superannuation funds, financial institutions and family offices across private and public equity, debt, venture capital and special situations; its venture activities include Tanarra Ventures and Tin Alley Ventures.

Blackbird is an Australia and New Zealand venture capital firm backing ambitious technology companies from the earliest stages through later growth. It invests across software, deep tech, climate, fintech, health and other technology-led sectors, with portfolio companies including Canva, SafetyCulture, Culture Amp, Zoox and Halter.

Brandon Capital Partners (Brandon Capital) is a life-sciences venture capital firm investing from seed through expansion capital and managing Brandon BioCatalyst, a life-science investment collaboration.

Square Peg is a venture capital firm that invests in emerging technology companies across the internet economy in Australia and New Zealand, Southeast Asia, and Israel.

Alceon Private Equity is a modern, ambitious and flexible private equity firm that does things a bit differently. We are diversely skilled business, operations and finance specialists within the $6 billion FUM Alceon Group. We invest in mid-market growth companies where we believe we can help more effectively and rapidly realise those companies' potential and consequently deliver outstanding returns to shareholders, founders and investors. We use modern tools, processes and playbooks that build from historically proven approaches but evolved to suit the future, not the past. As part of the successful Alceon Group, we have access to a large network of loyal investors with appetite to grow their wealth through investing in a variety of asset classes. Combined with Alceon Group's significant balance sheet, we think of this as our permanent capital. We then work with corporate advisers and company owners to identify high potential investment opportunities in which to deploy that capital as either a minority or majority stake. But we bring more than just money. We leverage our proven processes, governance and playbooks to work with our portfolio companies to level up their weaker operational areas and accelerate their growth plans. Unlike many of our competitors, we recognise each company has its own timeline so while we work to a successful exit, we do so on a schedule that will generate the best results for the business's shareholders.

Artesian Capital Management is a global alternative asset manager running separate debt and venture platforms and managing capital on behalf of institutional and other investors.

Bioscience Managers is an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare. Bioscience Managers invests in private and public healthcare companies with clear technological and market advantages in any territory, where we are confident that our engagement with management will deliver commercial success and returns for investors. We are both geographically and therapeutically agnostic. We invest in public and private healthcare companies in any territory which work in therapeutics, medical devices, diagnostics or digital health, which are in or near clinical development or commercialisation. Our strategy is to take a a meaningful stake in our investee companies, including board representation, advisory and or hands-on-roles to augment existing skills and to build a proactive and supportive relationships. We are part of the PhillipCapital Group, which has £30bn under management across 16 offices around the world.

Light Warrior is the Sali family's Melbourne investment group, established in 2016 after the sale of Swisse Wellness. It invests globally across public and private markets and real estate, with a venture arm for high-growth companies.

The CEM Group is a Melbourne based private investment group focussed on investing in and growing innovative businesses. CEM seeks to control investments in niche-oriented companies where we can partner with existing management teams to build industry leading businesses through internal growth and selective add-on acquisitions. The firm's original background was real estate (including Quest Apartments and a large number of real estate development assets), however it has since broadened its horizons. Since founding in February 2015, CEM has invested in over 25 companies.

Nash Capital is a private equity manager with $150m of funds under management. We invest between $10m-$30m in SME's across Australia and New Zealand, and seek to acquire companies between $10m to $100m in Enterprise Value.